These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27455456)

  • 1. Effect of Prescription Drug Coupons on Statin Utilization and Expenditures: A Retrospective Cohort Study.
    Daubresse M; Andersen M; Riggs KR; Alexander GC
    Pharmacotherapy; 2017 Jan; 37(1):12-24. PubMed ID: 27455456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of manufacturer coupon use in the statin market.
    Daugherty JB; Maciejewski ML; Farley JF
    J Manag Care Pharm; 2013; 19(9):765-72. PubMed ID: 24156645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of Missed Statin Prescription Use in an Administrative Claims Dataset.
    Wade RL; Patel JG; Hill JW; De AP; Harrison DJ
    J Manag Care Spec Pharm; 2017 Sep; 23(9):936-942. PubMed ID: 28854076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of prescription drug costs in the United States and the United Kingdom, Part 1: statins.
    Jick H; Wilson A; Wiggins P; Chamberlin DP
    Pharmacotherapy; 2012 Jan; 32(1):1-6. PubMed ID: 22392823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 10-year trends in statin utilization in Taiwan: a retrospective study using Taiwan's National Health Insurance Research Database.
    Hsieh HC; Hsu JC; Lu CY
    BMJ Open; 2017 May; 7(5):e014150. PubMed ID: 28515189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic and therapeutic statin switches and disruptions in therapy.
    Chapman RH; Benner JS; Girase P; Benigno M; Axelsen K; Liu LZ; Nichol MB
    Curr Med Res Opin; 2009 May; 25(5):1247-60. PubMed ID: 19344292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
    Luo J; Seeger JD; Donneyong M; Gagne JJ; Avorn J; Kesselheim AS
    JAMA Intern Med; 2016 Sep; 176(9):1317-23. PubMed ID: 27367749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort study.
    Watanabe JH; Kazerooni R; Bounthavong M
    J Manag Care Pharm; 2014 Jan; 20(1):43-50. PubMed ID: 24372459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme A reductase inhibitors on health care utilization: a Canadian population-based study.
    Einarson TR; Metge CJ; Iskedjian M; Mukherjee J
    Clin Ther; 2002 Dec; 24(12):2126-36. PubMed ID: 12581550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018.
    Lin SY; Baumann K; Zhou C; Zhou W; Cuellar AE; Xue H
    JAMA Netw Open; 2021 Nov; 4(11):e2135371. PubMed ID: 34807258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey.
    Salami JA; Warraich H; Valero-Elizondo J; Spatz ES; Desai NR; Rana JS; Virani SS; Blankstein R; Khera A; Blaha MJ; Blumenthal RS; Lloyd-Jones D; Nasir K
    JAMA Cardiol; 2017 Jan; 2(1):56-65. PubMed ID: 27842171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching statins in Norway after new reimbursement policy: a nationwide prescription study.
    Sakshaug S; Furu K; Karlstad Ø; Rønning M; Skurtveit S
    Br J Clin Pharmacol; 2007 Oct; 64(4):476-81. PubMed ID: 17441934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specialty drug coupons lower out-of-pocket costs and may improve adherence at the risk of increasing premiums.
    Starner CI; Alexander GC; Bowen K; Qiu Y; Wickersham PJ; Gleason PP
    Health Aff (Millwood); 2014 Oct; 33(10):1761-9. PubMed ID: 25288420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moving branded statins to lowest copay tier improves patient adherence.
    Chen SY; Shah SN; Lee YC; Boulanger L; Mardekian J; Kuznik A
    J Manag Care Pharm; 2014 Jan; 20(1):34-42. PubMed ID: 24372458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
    Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
    Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Statin Use in Seniors 1999 to 2013: Time Series Analysis.
    Minard LV; Corkum A; Sketris I; Fisher J; Zhang Y; Saleh A
    PLoS One; 2016; 11(7):e0158608. PubMed ID: 27434392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of factors associated with statin adherence in a hierarchical model considering physician, pharmacy, patient, and prescription characteristics.
    Pedan A; Varasteh L; Schneeweiss S
    J Manag Care Pharm; 2007; 13(6):487-96. PubMed ID: 17672810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Web-based survey to assess the perceptions of managed care organization representatives on use of copay subsidy coupons for prescription drugs.
    Nemlekar P; Shepherd M; Lawson K; Rush S
    J Manag Care Pharm; 2013 Oct; 19(8):602-8. PubMed ID: 24074006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated With Manufacturer Drug Coupon Use at US Pharmacies.
    Kang SY; Sen AP; Levy JF; Long J; Alexander GC; Anderson GF
    JAMA Health Forum; 2021 Aug; 2(8):e212123. PubMed ID: 35977193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of restricted reimbursement on the use of statins in Finland: a register-based study.
    Martikainen JE; Saastamoinen LK; Korhonen MJ; Enlund H; Helin-Salmivaara A
    Med Care; 2010 Sep; 48(9):761-6. PubMed ID: 20706164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.